Citations (185)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Wubetu Yihunie, Bekalu Kebede, Bantayehu Addis Tegegne, Melese Getachew, Dehnnet Abebe, Yibeltal Aschale, Habtamu Belew & Bereket Bahiru. (2023) Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults. Clinical Pharmacology: Advances and Applications 15, pages 21-32.
Read now
Read now
Michael Quagliata, Anna Maria Papini & Paolo Rovero. (2023) Malaria vaccines. Expert Opinion on Therapeutic Patents 33:3, pages 169-178.
Read now
Read now
Navneet Arora, Lokhesh C Anbalagan & Ashok K Pannu. (2021) Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?. Risk Management and Healthcare Policy 14, pages 1033-1039.
Read now
Read now
Daniel Fernandez-Ruiz, Maria N. de Menezes, Lauren E. Holz, Sonia Ghilas, William R. Heath & Lynette Beattie. (2021) Harnessing liver-resident memory T cells for protection against malaria. Expert Review of Vaccines 20:2, pages 127-141.
Read now
Read now
Palak N. Patel & Niraj Tolia. (2021) Structural vaccinology of malaria transmission-blocking vaccines. Expert Review of Vaccines 20:2, pages 199-214.
Read now
Read now
Matthew B. Laurens. (2020) RTS,S/AS01 vaccine (Mosquirix™): an overview. Human Vaccines & Immunotherapeutics 16:3, pages 480-489.
Read now
Read now
Philippe Moris, Erik Jongert & Robbert G. van der Most. (2018) Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine. Human Vaccines & Immunotherapeutics 14:1, pages 17-27.
Read now
Read now
Ming Tan & Xi Jiang. (2017) Recent advancements in combination subunit vaccine development. Human Vaccines & Immunotherapeutics 13:1, pages 180-185.
Read now
Read now
Michael R. Hollingdale & Martha Sedegah. (2017) Development of whole sporozoite malaria vaccines. Expert Review of Vaccines 16:1, pages 45-54.
Read now
Read now
Pascale Vandoolaeghe & Lode Schuerman. (2016) The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Expert Review of Vaccines 15:12, pages 1481-1493.
Read now
Read now
Katie L. Flanagan, Kirsty L. Wilson & Magdalena Plebanski. (2016) Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design. Expert Review of Vaccines 15:3, pages 389-399.
Read now
Read now
Daria Nikolaeva, Simon J Draper & Sumi Biswas. (2015) Toward the development of effective transmission-blocking vaccines for malaria. Expert Review of Vaccines 14:5, pages 653-680.
Read now
Read now
Gladys J Keitany, Marissa Vignali & Ruobing Wang. (2014) Live attenuated pre-erythrocytic malaria vaccines. Human Vaccines & Immunotherapeutics 10:10, pages 2903-2909.
Read now
Read now
Geert Leroux-Roels, Isabel Leroux-Roels, Frédéric Clement, Opokua Ofori-Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W Ripley Ballou & Joe Cohen. (2014) Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics 10:8, pages 2211-2219.
Read now
Read now
Kai Matuschewski. (2013) Murine infection models for vaccine development. Human Vaccines & Immunotherapeutics 9:3, pages 450-456.
Read now
Read now
Kenny Roose, Sarah De Baets, Bert Schepens & Xavier Saelens. (2013) Hepatitis B core–based virus–like particles to present heterologous epitopes. Expert Review of Vaccines 12:2, pages 183-198.
Read now
Read now
Mark J Geels, Egeruan B Imoukhuede, Nathalie Imbault, Harry van Schooten, Terry McWade, Marita Troye-Blomberg, Roland Dobbelaer, Alister G Craig & Odile Leroy. (2011) European Vaccine Initiative: lessons from developing malaria vaccines. Expert Review of Vaccines 10:12, pages 1697-1708.
Read now
Read now
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
Cevayir Coban, Toshihiro Horii, Shizuo Akira & Ken J Ishii. (2010) TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine. Expert Review of Vaccines 9:7, pages 775-784.
Read now
Read now
Articles from other publishers (166)
Manish Dhawan, AbdulRahman A. Saied & Manish Sharma. (2023) Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?. Health Sciences Review 9, pages 100127.
Crossref
Crossref
Clifford T.H. Hayashi, Yi Cao, Fidel Zavala, Hayk Simonyan, Colin N. Young & Nirbhay Kumar. (2023) Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences. Vaccine 41:46, pages 6824-6833.
Crossref
Crossref
Mariah Hassert, Sahaana Arumugam & John T. Harty. (2023)
Memory
CD8
+ T cell‐mediated protection against liver‐stage malaria
. Immunological Reviews 316:1, pages 84-103.
Crossref
Crossref
Cheikh Cambel Dieng, Colby T. Ford, Anita Lerch, Dickson Doniou, Kovidh Vegesna, Daniel Janies, Liwang Cui, Linda Amoah, Yaw Afrane & Eugenia Lo. (2023) Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy. Infection, Genetics and Evolution 110, pages 105418.
Crossref
Crossref
Dongliang Wang, Youqing Yuan, Bin Liu, Neal D. Epstein & Yi Yang. (2023) Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines. International Journal of Biological Macromolecules 236, pages 123979.
Crossref
Crossref
Eric Kyei-Baafour, Kwadwo A. Kusi, Mavis Oppong, Abena F. Frempong, Belinda Aculley, Ebenezer A. Ofori, Michael Theisen, Margaret Kweku, Bright Adu, Lars Hviid & Michael F. Ofori. (2023) Serology reveals micro-differences in Plasmodium falciparum transmission in the Hohoe municipality of Ghana. Frontiers in Parasitology 2.
Crossref
Crossref
Pankaj Chandley, Ravikant Ranjan, Sudhir Kumar & Soma Rohatgi. (2023) Host-parasite interactions during Plasmodium infection: Implications for immunotherapies. Frontiers in Immunology 13.
Crossref
Crossref
Amy Ruth Quinton, Harry Benjamin McDowell & Egbert Hoiczyk. 2023.
1
48
.
Lode Schuerman & Christian Ockenhouse. 2023. Plotkin's Vaccines. Plotkin's Vaccines
617
628.e7
.
Ketaki Ramani. 2022. Drug Development for Malaria. Drug Development for Malaria
25
44
.
Oluwaseyi Muyiwa Egbewande. (2022) The RTS,S malaria vaccine: Journey from conception to recommendation. Public Health in Practice, pages 100283.
Crossref
Crossref
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, Ebtesam A. Al-Suhaimi & Young Sup Lee. (2022) Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines 10:5, pages 713.
Crossref
Crossref
Photini Sinnis & David A. Fidock. (2022) The RTS,S vaccine—a chance to regain the upper hand against malaria?. Cell 185:5, pages 750-754.
Crossref
Crossref
Ilka Wahl & Hedda Wardemann. (2022)
How to induce protective humoral immunity against
Plasmodium falciparum
circumsporozoite protein
. Journal of Experimental Medicine 219:2.
Crossref
Crossref
Liriye Kurtovic, Damien R. Drew, Arlene E. Dent, James W. Kazura & James G. Beeson. (2021) Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity. Frontiers in Immunology 12.
Crossref
Crossref
Robert M. Mugo, Kennedy Mwai, Jedidah Mwacharo, Faiz M. Shee, Jennifer N. Musyoki, Juliana Wambua, Edward Otieno, Philip Bejon & Francis M. Ndungu. (2021) Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children. Malaria Journal 20:1.
Crossref
Crossref
Liriye Kurtovic, Tanmaya Atre, Gaoqian Feng, Bruce D Wines, Jo-Anne Chan, Michelle J Boyle, Damien R Drew, P Mark Hogarth, Freya J I Fowkes, Elke S Bergmann-Leitner & James G Beeson. (2021) Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial. The Journal of Infectious Diseases 224:7, pages 1128-1138.
Crossref
Crossref
Daniel ChandramohanIssaka ZongoIssaka SagaraMatthew CairnsRakiswendé-Serge YerbangaModibo DiarraFrédéric NikièmaAmadou TapilyFrédéric SompougdouDjibrilla IssiakaCharles ZoungranaKoualy SanogoAlassane HaroMahamadou KayaAbdoul-Aziz SienouSeydou TraoreAlmahamoudou MahamarIsmaila TheraKalifa DiarraAmagana DoloIrene KuepferPaul SnellPaul MilliganChristian OckenhouseOpokua Ofori-AnyinamHalidou TintoAbdoulaye DjimdeJean-Bosco OuédraogoAlassane DickoBrian Greenwood. (2021) Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. New England Journal of Medicine 385:11, pages 1005-1017.
Crossref
Crossref
Chao Pan, Hua Yue, Li Zhu, Guang-hui Ma & Heng-liang Wang. (2021) Prophylactic vaccine delivery systems against epidemic infectious diseases. Advanced Drug Delivery Reviews 176, pages 113867.
Crossref
Crossref
Kelly E. Seaton, Rachel L. Spreng, Milite Abraha, Matthew Reichartz, Michelle Rojas, Frederick FeelyIIII, Richard H. C. Huntwork, Sheetij Dutta, Sarah V. Mudrak, S. Munir Alam, Scott Gregory, Erik Jongert, Margherita Coccia, Fernando Ulloa-Montoya, Ulrike Wille-Reece, Georgia D. Tomaras & S. Moses Dennison. (2021) Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection. npj Vaccines 6:1.
Crossref
Crossref
Calvin Hon, Johannes Friesen, Alyssa Ingmundson, Diana Scheppan, Julius C. R. Hafalla, Katja Müller & Kai Matuschewski. (2021) Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of Plasmodium Sporozoites Indicates Diversion of Cellular Immunity. Frontiers in Microbiology 12.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Vahid Raissi, Soudabeh Etemadi, Muhammad Ibrahim Getso, Ahmad Mehravaran & Omid Raiesi. (2021) Structure-genetic diversity and recombinant protein of circumsporozoite protein (CSP) of vivax malaria antigen: A potential malaria vaccine candidate. Gene Reports 23, pages 101132.
Crossref
Crossref
Katharine A. Collins, Florian Brod, Rebecca Snaith, Marta Ulaszewska, Rhea J. Longley, Ahmed M. Salman, Sarah C. Gilbert, Alexandra J. Spencer, David Franco, W. Ripley Ballou & Adrian V. S. Hill. (2021) Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice. Scientific Reports 11:1.
Crossref
Crossref
Brian Nguyen & Niraj H. Tolia. (2021) Protein-based antigen presentation platforms for nanoparticle vaccines. npj Vaccines 6:1.
Crossref
Crossref
Katja Müller, Matthew P Gibbins, Mark Roberts, Arturo Reyes‐Sandoval, Adrian V S Hill, Simon J Draper, Kai Matuschewski, Olivier Silvie & Julius Clemence R Hafalla. (2021) Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination. EMBO Molecular Medicine 13:4.
Crossref
Crossref
Gunnar Lindahl. (2021) Subdominance in Antibody Responses: Implications for Vaccine Development. Microbiology and Molecular Biology Reviews 85:1.
Crossref
Crossref
S Moses Dennison, Matthew Reichartz, Milite Abraha, Rachel L Spreng, Ulrike Wille-Reece, Sheetij Dutta, Erik Jongert, S Munir Alam & Georgia D Tomaras. (2021) Magnitude, Specificity, and Avidity of Sporozoite-Specific Antibodies Associate With Protection Status and Distinguish Among RTS,S/AS01 Dose Regimens. Open Forum Infectious Diseases 8:2.
Crossref
Crossref
Sidhartha Chaudhury, Randall S. MacGill, Angela M. Early, Jessica S. Bolton, C. Richter King, Emily Locke, Tony Pierson, Dyann F. Wirth, Daniel E. Neafsey & Elke S. Bergmann-Leitner. (2021) Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine. Vaccine 39:6, pages 968-975.
Crossref
Crossref
Lucie Jelínková, Hugo Jhun, Allison Eaton, Nikolai Petrovsky, Fidel Zavala & Bryce Chackerian. (2021) An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein. npj Vaccines 6:1.
Crossref
Crossref
Jessica Bolton, Sidhartha Chaudhury, Randall S. MacGill, Angela M. Early, C. Richter King, Emily Locke, Daniel E. Neafsey & Elke S. Bergmann-Leitner. (2021) Multiplex serological assay for establishing serological profiles of polymorphic, closely related peptide antigens. MethodsX 8, pages 101345.
Crossref
Crossref
Janez Ferluga, Iesha Singh, Sashmita Rout, Ahmed Al-Qahtani, Hadida Yasmin & Uday Kishore. 2021. Microbial Pathogenesis. Microbial Pathogenesis
273
291
.
Yukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, António M. Mendes, Rianne van der Laak, Angelika Sturm, Fiona J. A. Geurten, Shinya Miyazaki, Severine Chevalley-Maurel, Jai Ramesar, Surendra K. Kolli, Hans Kroeze, Roos van Schuijlenburg, Ahmed M. Salman, Brandon K. Wilder, Arturo Reyes-Sandoval, Koen J. Dechering, Miguel Prudêncio, Chris J. Janse, Shahid M. Khan & Blandine Franke-Fayard. (2020) Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Jessica Molina-Franky, Laura Cuy-Chaparro, Anny Camargo, César Reyes, Marcela Gómez, David Ricardo Salamanca, Manuel Alfonso Patarroyo & Manuel Elkin Patarroyo. (2020) Plasmodium falciparum pre-erythrocytic stage vaccine development. Malaria Journal 19:1.
Crossref
Crossref
François P. Roman, Margherita Coccia & Lode Schuerman. (2020) Commentary in reply to a publication on Plasmodium falciparum pre-erythrocytic stage vaccine development. Malaria Journal 19:1.
Crossref
Crossref
Juliette Fortpied, Sylvie Collignon, Nicolas Moniotte, Frédéric Renaud, Babak Bayat & Dominique Lemoine. (2020) The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01. Malaria Journal 19:1.
Crossref
Crossref
Rama Raghunandan, Bryan T. Mayer, Yevel Flores-Garcia, Monica W. Gerber, Raphael Gottardo, Hugo Jhun, Sonia M. Herrera, Daniel W. Perez-Ramos, Emily Locke, C. Richter King & Fidel Zavala. (2020) Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein. Malaria Journal 19:1.
Crossref
Crossref
Imen Ayadi, Saidou Balam, Régine Audran, Jean-Pierre Bikorimana, Issa Nebie, Mahamadou Diakité, Ingrid Felger, Marcel Tanner, François Spertini, Giampietro Corradin, Myriam Arevalo, Socrates Herrera & Valentina Agnolon. (2020) P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine. Frontiers in Immunology 11.
Crossref
Crossref
Evelia M. Milán-Noris, Elizabeth Monreal-Escalante, Sergio Rosales-Mendoza, Ruth E. Soria-Guerra, Osman Radwan, John A. Juvik & Schuyler S. Korban. (2020) An AMA1/MSP119 Adjuvanted Malaria Transplastomic Plant-Based Vaccine Induces Immune Responses in Test Animals. Molecular Biotechnology 62:10, pages 534-545.
Crossref
Crossref
Daniel Chandramohan, Alassane Dicko, Issaka Zongo, Issaka Sagara, Matthew Cairns, Irene Kuepfer, Modibo Diarra, Amadou Tapily, Djibrilla Issiaka, Koualy Sanogo, Almahamoudou Mahamar, Frederic Sompougdou, Serge Yerbanga, Ismaila Thera, Paul Milligan, Halidou Tinto, Opokua Ofori-Anyinam, Jean-Bosco Ouedraogo & B Greenwood. (2020)
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01
E
vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
. BMJ Open 10:9, pages e035433.
Crossref
Crossref
Shadi Saleh, Nour El Arnaout, Lina Abdouni, Zeinab Jammoul, Noha Hachach & Amlan Dasgupta. (2020) Sijilli: A Scalable Model of Cloud-Based Electronic Health Records for Migrating Populations in Low-Resource Settings. Journal of Medical Internet Research 22:8, pages e18183.
Crossref
Crossref
Camila Marques-da-Silva, Kristen Peissig & Samarchith P. Kurup. (2020) Pre-Erythrocytic Vaccines against Malaria. Vaccines 8:3, pages 400.
Crossref
Crossref
Rajagopal Murugan, Stephen W. Scally, Giulia Costa, Ghulam Mustafa, Elaine Thai, Tizian Decker, Alexandre Bosch, Katherine Prieto, Elena A. Levashina, Jean-Philippe Julien & Hedda Wardemann. (2020) Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs. Nature Medicine 26:7, pages 1135-1145.
Crossref
Crossref
Lina Sánchez, Marta Vidal, Chenjerai Jairoce, Ruth Aguilar, Itziar Ubillos, Inocencia Cuamba, Augusto J. Nhabomba, Nana Aba Williams, Núria Díez-Padrisa, David Cavanagh, Evelina Angov, Ross L. Coppel, Deepak Gaur, James G. Beeson, Sheetij Dutta, Pedro Aide, Joseph J. Campo, Gemma Moncunill & Carlota Dobaño. (2020) Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. npj Vaccines 5:1.
Crossref
Crossref
Isaie J. Reuling, António M. Mendes, Gerdie M. de Jong, Amanda Fabra-García, Helena Nunes-Cabaço, Geert-Jan van GemertWouter Graumans, Luc E. Coffeng, Sake J. de Vlas, Annie S. P. Yang, Cynthia Lee, Yimin WuAshley J. Birkett, Christian F. OckenhouseRob KoelewijnJaap J. van Hellemond, Perry J. J. van Genderen, Robert W. Sauerwein & Miguel Prudêncio. (2020)
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against
Plasmodium falciparum
malaria
. Science Translational Medicine 12:544.
Crossref
Crossref
Kwaku Poku Asante, Daniel Ansong, Seyram Kaali, Samuel Adjei, Marc Lievens, Lydia Nana Badu, Prince Agyapong Darko, Patrick Boakye Yiadom Buabeng, Owusu Boahen, Theresa Maria Rettig, Clara Agutu, Samuel Benard Ekow Harrison, Yaw Ntiamoah, Japhet Adomako Anim, Elisha Adeniji, Albert Agordo Dornudo, Emilia Gvozdenovic, David Dosoo, David Sambian, Harry Owusu-Boateng, Elvis Ato Wilson, Frank Prempeh, Pascale Vandoolaeghe, Lode Schuerman, Seth Owusu-Agyei, Tsiri Agbenyega & Opokua Ofori-Anyinam. (2020) Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial. Vaccine 38:18, pages 3411-3421.
Crossref
Crossref
Irina Dobrescu, Tarsila Mendes de Camargo, Alba Marina Gimenez, Oscar Murillo, Kelly Nazaré da Silva Amorim, Claudio Romero Farias Marinho, Irene Silva Soares, Silvia Beatriz Boscardin & Daniel Youssef Bargieri. (2020) Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119. Frontiers in Immunology 11.
Crossref
Crossref
Joan Kha-Tu Ho, Beena Jeevan-Raj & Hans-Jürgen Netter. (2020) Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. Viruses 12:2, pages 126.
Crossref
Crossref
Machteld van den Berg, Bernhards Ogutu, Nelson K. Sewankambo, Nikola Biller-Andorno & Marcel Tanner. (2019) RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials. Trials 20:1.
Crossref
Crossref
Bhavna Chawla, Babita Mahajan, Miranda Oakley, Victoria F. Majam, Arnel Belmonte, Martha Sedegah, Richard L. ShimpJr.Jr., David C. Kaslow & Sanjai Kumar. (2019) Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine. Infection and Immunity 87:10.
Crossref
Crossref
Benjamin Spreng, Hannah Fleckenstein, Patrick Kübler, Claudia Di Biagio, Madlen Benz, Pintu Patra, Ulrich S Schwarz, Marek Cyrklaff & Friedrich Frischknecht. (2019)
Microtubule number and length determine cellular shape and function in
Plasmodium
. The EMBO Journal 38:15.
Crossref
Crossref
Halidou Tinto, Walter Otieno, Samwel Gesase, Hermann Sorgho, Lucas Otieno, Edwin Liheluka, Innocent Valéa, Valentine Sing'oei, Anangisye Malabeja, Daniel Valia, Anne Wangwe, Emilia Gvozdenovic, Yolanda Guerra Mendoza, Erik Jongert, Marc Lievens, François Roman, Lode Schuerman & John Lusingu. (2019) Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. The Lancet Infectious Diseases 19:8, pages 821-832.
Crossref
Crossref
Anny Jineth Camargo Mancipe, Diana Diaz Arévalo, David Ricardo Salamanca, Laura Esperanza Cuy Chaparro & Diego Fernando Camargo Mancipe. (2019) Revisión de estudios pre-clínicos de candidatos a vacuna contra la malaria causada por Plasmodium falciparum. Revista Investigación en Salud Universidad de Boyacá 6:2, pages 200-223.
Crossref
Crossref
Yun Shan Goh, Daniel McGuire & Laurent Rénia. (2019) Vaccination With Sporozoites: Models and Correlates of Protection. Frontiers in Immunology 10.
Crossref
Crossref
Alicia Cawlfield, Christopher J. Genito, Zoltan Beck, Elke S. Bergmann-Leitner, Alexis A. Bitzer, Kimberly Soto, Xiaoyan Zou, Sri H. Hadiwidjojo, Robert V. Gerbasi, Anna B. Mullins, Amy Noe, Norman C. Waters, Carl R. Alving, Gary R. Matyas & Sheetij Dutta. (2019) Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ). Vaccine 37:29, pages 3793-3803.
Crossref
Crossref
Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski, Istvan Toth, Danielle I. Stanisic & Michael F. Good. (2019) Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines. Frontiers in Immunology 10.
Crossref
Crossref
D. Scott Wilson, Sachiko Hirosue, Michal M. Raczy, Leonardo Bonilla-Ramirez, Laura Jeanbart, Ruyi Wang, Marcin Kwissa, Jean-Francois Franetich, Maria A. S. Broggi, Giacomo Diaceri, Xavier Quaglia-Thermes, Dominique Mazier, Melody A. Swartz & Jeffrey A. Hubbell. (2019) Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nature Materials 18:2, pages 175-185.
Crossref
Crossref
Florian Brod, Kazutoyo Miura, Iona Taylor, Yuanyuan Li, Arianna Marini, Ahmed M. Salman, Alexandra J. Spencer, Carole A. Long & Sumi Biswas. (2018) Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice. Frontiers in Immunology 9.
Crossref
Crossref
S. Moses Dennison, Matthew Reichartz, Kelly E. Seaton, Sheetij Dutta, Ulrike Wille-Reece, Adrian V. S. Hill, Katie J. Ewer, Wes Rountree, Marcella Sarzotti-Kelsoe, Daniel A. Ozaki, S. Munir Alam & Georgia D. Tomaras. (2018)
Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with
Plasmodium falciparum
Circumsporozoite Protein Antigens
. The Journal of Immunology 201:4, pages 1315-1326.
Crossref
Crossref
Roland Frank, Michael Gabel, Kirsten Heiss, Ann-Kristin Mueller & Frederik Graw. (2018) Varying Immunizations With Plasmodium Radiation-Attenuated Sporozoites Alter Tissue-Specific CD8+ T Cell Dynamics. Frontiers in Immunology 9.
Crossref
Crossref
Desiree Witte, Nigel A. Cunliffe, Ann M. Turner, Edward Ngulube, Opokua Ofori-Anyinam, Johan Vekemans, Philips Chimpeni, Marc Lievens, Trevor P. Wilson, Jenala Njiram’madzi, Yolanda Guerra Mendoza & Amanda Leach. (2018) Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen. Pediatric Infectious Disease Journal 37:5, pages 483-491.
Crossref
Crossref
Elizabeth M. Parzych, Kazutoyo Miura, Aarti Ramanathan, Carole A. Long & James M. BurnsJr.Jr.. (2018)
Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant
Pf
s25, a Leading Transmission-Blocking Vaccine Candidate
. Infection and Immunity 86:1.
Crossref
Crossref
W. Ripley Ballou & Johan Vekemans. 2018. Plotkin's Vaccines. Plotkin's Vaccines
561
566.e3
.
José A. Stoute. 2018. Complement Activation in Malaria Immunity and Pathogenesis. Complement Activation in Malaria Immunity and Pathogenesis
125
137
.
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittmala & Sasithon Pukrittayakamee. (2017)
RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of
Plasmodium falciparum
. Emerging Topics in Life Sciences 1:6, pages 533-537.
Crossref
Crossref
Gianna Triller, Stephen W. Scally, Giulia Costa, Maria Pissarev, Cornelia Kreschel, Alexandre Bosch, Eric Marois, Brandon K. Sack, Rajagopal Murugan, Ahmed M. Salman, Chris J. Janse, Shahid M. Khan, Stefan H.I. Kappe, Ayola A. Adegnika, Benjamin Mordmüller, Elena A. Levashina, Jean-Philippe Julien & Hedda Wardemann. (2017) Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies. Immunity 47:6, pages 1197-1209.e10.
Crossref
Crossref
David OyenJonathan L. TorresUlrike Wille-ReeceChristian F. OckenhouseDaniel EmerlingJacob GlanvilleWayne VolkmuthYevel Flores-GarciaFidel ZavalaAndrew B. WardC. Richter KingIan A. Wilson. (2017)
Structural basis for antibody recognition of the NANP repeats in
Plasmodium falciparum
circumsporozoite protein
. Proceedings of the National Academy of Sciences 114:48.
Crossref
Crossref
Alba Marina Gimenez, Luciana Chagas Lima, Katia Sanches Françoso, Priscila M. A. Denapoli, Raquel Panatieri, Daniel Y. Bargieri, Jean-Michel Thiberge, Chiara Andolina, Francois Nosten, Laurent Renia, Ruth S. Nussenzweig, Victor Nussenzweig, Rogerio Amino, Mauricio M. Rodrigues & Irene S. Soares. (2017) Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite. Frontiers in Immunology 8.
Crossref
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Crossref
Julie G. Burel, Simon H. Apte, Penny L. Groves, Michelle J. Boyle, Christine Langer, James G. Beeson, James S. McCarthy & Denise L. Doolan. (2017) Dichotomous miR expression and immune responses following primary blood-stage malaria. JCI Insight 2:15.
Crossref
Crossref
Renu Tuteja. (2017) Unraveling the importance of the malaria parasite helicases. The FEBS Journal 284:16, pages 2592-2603.
Crossref
Crossref
Kai Matuschewski. (2017) Vaccines against malaria-still a long way to go. The FEBS Journal 284:16, pages 2560-2568.
Crossref
Crossref
Hayley K. Charlton Hume & Linda H.L. Lua. (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35:35, pages 4480-4485.
Crossref
Crossref
Susheel K. Singh, Susan Thrane, Christoph M. Janitzek, Morten A. Nielsen, Thor G. Theander, Michael Theisen, Ali Salanti & Adam F. Sander. (2017) Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. Vaccine 35:30, pages 3726-3732.
Crossref
Crossref
Robert A. van den Berg, Margherita Coccia, W. Ripley Ballou, Kent E. Kester, Christian F. Ockenhouse, Johan Vekemans, Erik Jongert, Arnaud M. Didierlaurent & Robbert G. van der Most. (2017) Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial. Frontiers in Immunology 8.
Crossref
Crossref
Friedrich Frischknecht & Kai Matuschewski. (2017)
Plasmodium
Sporozoite Biology
. Cold Spring Harbor Perspectives in Medicine 7:5, pages a025478.
Crossref
Crossref
Rhea J. Longley, Benedict R. Halbroth, Ahmed M. Salman, Katie J. Ewer, Susanne H. Hodgson, Chris J. Janse, Shahid M. Khan, Adrian V. S. Hill & Alexandra J. Spencer. (2017) Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Infection and Immunity 85:3.
Crossref
Crossref
Dmitri KazminHelder I. NakayaEva K. LeeMatthew J. JohnsonRobbert van der MostRobert A. van den BergW. Ripley BallouErik JongertUlrike Wille-ReeceChristian OckenhouseAlan AderemDaniel E. ZakJerald SadoffJenny HendriksJens WrammertRafi AhmedBali Pulendran. (2017) Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proceedings of the National Academy of Sciences 114:9, pages 2425-2430.
Crossref
Crossref
Aditya Prasad Patra, Shobhona Sharma & Sri Rama Koti Ainavarapu. (2017) Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region. Journal of Biological Chemistry 292:6, pages 2110-2119.
Crossref
Crossref
Lisanne A. van de Schans, Jona Walk, Isaie J. Reuling & Robert W. Sauerwein. (2016) Huidige status en ontwikkeling van malariavaccins. Bijblijven 33:1, pages 62-69.
Crossref
Crossref
A.M. Didierlaurent, A. Berger, T.C. Heineman, V. Henderickx, F. Tavares Da Silva, J. Vekemans, G. Voss & N. Garçon. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
265
285
.
Johan Vekemans. 2017. Malaria. Malaria
139
156
.
António M. Mendes, Anja Scholzen, Ann-Kristin Mueller, Shahid M. Khan, Robert W. Sauerwein & Miguel Prudêncio. 2017. Malaria. Malaria
99
137
.
Kristina Radin, Frederic Clement, Erik Jongert, Yann G. J. Sterckx, Christian Ockenhouse, Jason Regules, Franck Lemiale & Geert Leroux-Roels. (2016) A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum. Malaria Journal 15:1.
Crossref
Crossref
Alexander Boes, Holger Spiegel, Robin Kastilan, Susanne Bethke, Nadja Voepel, Ivana Chudobová, Judith M. Bolscher, Koen J. Dechering, Rolf Fendel, Johannes F. Buyel, Andreas Reimann, Stefan Schillberg & Rainer Fischer. (2016) Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail. Malaria Journal 15:1.
Crossref
Crossref
James M. BurnsJr.Jr., Kazutoyo Miura, JoAnn Sullivan, Carole A. Long & John W. Barnwell. (2016) Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Malaria Journal 15:1.
Crossref
Crossref
Alan F. Cowman, Julie Healer, Danushka Marapana & Kevin Marsh. (2016) Malaria: Biology and Disease. Cell 167:3, pages 610-624.
Crossref
Crossref
Lucas Otieno, Martina Oneko, Walter Otieno, Joseph Abuodha, Emmanuel Owino, Chris Odero, Yolanda Guerra Mendoza, Ben Andagalu, Norbert Awino, Karen Ivinson, Dirk Heerwegh, Nekoye Otsyula, Maria Oziemkowska, Effua Abigail Usuf, Allan Otieno, Kephas Otieno, Didier Leboulleux, Amanda Leach, Janet Oyieko, Laurence Slutsker, Marc Lievens, Jessica Cowden, Didier Lapierre, Simon Kariuki, Bernhards Ogutu, Johan Vekemans & Mary J Hamel. (2016) Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial. The Lancet Infectious Diseases 16:10, pages 1134-1144.
Crossref
Crossref
Jason A. Regules, Susan B. Cicatelli, Jason W. Bennett, Kristopher M. Paolino, Patrick S. Twomey, James E. Moon, April K. Kathcart, Kevin D. Hauns, Jack L. Komisar, Aziz N. Qabar, Silas A. Davidson, Sheetij Dutta, Matthew E. Griffith, Charles D. Magee, Mariusz Wojnarski, Jeffrey R. Livezey, Adrian T. Kress, Paige E. Waterman, Erik Jongert, Ulrike Wille-Reece, Wayne Volkmuth, Daniel Emerling, William H. Robinson, Marc Lievens, Danielle Morelle, Cynthia K. Lee, Bebi Yassin-Rajkumar, Richard Weltzin, Joe Cohen, Robert M. Paris, Norman C. Waters, Ashley J. Birkett, David C. Kaslow, W. Ripley Ballou, Christian F. Ockenhouse & Johan Vekemans. (2016) Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study. Journal of Infectious Diseases 214:5, pages 762-771.
Crossref
Crossref
Cate Speake, Alexander Pichugin, Tejram Sahu, Vlad Malkov, Robert Morrison, Ying Pei, Laure Juompan, Neta Milman, Stasya Zarling, Charles Anderson, Sharon Wong-Madden, Jason Wendler, Andrew Ishizuka, Zachary W. MacMillen, Valentino Garcia, Stefan H. I. Kappe, Urszula Krzych & Patrick E. Duffy. (2016) Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein. PLOS ONE 11:7, pages e0159449.
Crossref
Crossref
Jason W. Bennett, Anjali Yadava, Donna Tosh, Jetsumon Sattabongkot, Jack Komisar, Lisa A. Ware, William F. McCarthy, Jessica J. Cowden, Jason Regules, Michele D. Spring, Kristopher Paolino, Joshua D. Hartzell, James F. Cummings, Thomas L. Richie, Joanne Lumsden, Edwin Kamau, Jittawadee Murphy, Cynthia Lee, Falgunee Parekh, Ashley Birkett, Joe Cohen, W. Ripley Ballou, Mark E. Polhemus, Yannick F. Vanloubbeeck, Johan Vekemans & Christian F. Ockenhouse. (2016) Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. PLOS Neglected Tropical Diseases 10:2, pages e0004423.
Crossref
Crossref
Leticia Higa, Ana Perez, Priscila Schilrreff, Maria Morilla & Eder Romero. 2016. Nanotechnology and Drug Delivery, Volume Two. Nanotechnology and Drug Delivery, Volume Two
324
369
.
Jacinto López-Sagaseta, Enrico Malito, Rino Rappuoli & Matthew J. Bottomley. (2016) Self-assembling protein nanoparticles in the design of vaccines. Computational and Structural Biotechnology Journal 14, pages 58-68.
Crossref
Crossref
Brian Greenwood & Ogobara K Doumbo. (2016) Implementation of the malaria candidate vaccine RTS,S/AS01. The Lancet 387:10016, pages 318-319.
Crossref
Crossref
Johan Vekemans. 2016. The Vaccine Book. The Vaccine Book
385
399
.
Julie Healer & Alan F. Cowman. 2016. Molecular Parasitology. Molecular Parasitology
509
525
.
Nimfa Teneza-Mora, Joanne Lumsden & Eileen Villasante. (2015) A malaria vaccine for travelers and military personnel: Requirements and top candidates. Vaccine 33:52, pages 7551-7558.
Crossref
Crossref
Ashley J. Birkett. (2015) Building an effective malaria vaccine pipeline to address global needs. Vaccine 33:52, pages 7538-7543.
Crossref
Crossref
Simon J. Draper, Evelina Angov, Toshihiro Horii, Louis H. Miller, Prakash Srinivasan, Michael Theisen & Sumi Biswas. (2015) Recent advances in recombinant protein-based malaria vaccines. Vaccine 33:52, pages 7433-7443.
Crossref
Crossref
David C. Kaslow & Sophie Biernaux. (2015) RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap. Vaccine 33:52, pages 7425-7432.
Crossref
Crossref
Selidji T Agnandji, José F Fernandes, Emmanuel B Bache & Michael Ramharter. (2015) Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I–III trials. Future Microbiology 10:10, pages 1553-1578.
Crossref
Crossref
Nishant K. Jain, Neha Sahni, Ozan S. Kumru, Sangeeta B. Joshi, David B. Volkin & C. Russell Middaugh. (2015) Formulation and stabilization of recombinant protein based virus-like particle vaccines. Advanced Drug Delivery Reviews 93, pages 42-55.
Crossref
Crossref
Stanley A. Plotkin. (2015) Increasing Complexity of Vaccine Development. Journal of Infectious Diseases 212:suppl 1, pages S12-S16.
Crossref
Crossref
. (2015) Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. The Lancet 386:9988, pages 31-45.
Crossref
Crossref
Lawrence Segal, Danielle Morelle, Mark Blee, Emma Moore, Micaela Damsten, Kai Chiu Liu, Eric Destexhe & Nathalie Garçon. (2015) Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits. Regulatory Toxicology and Pharmacology 71:2, pages 269-278.
Crossref
Crossref
Satarudra Prakash SinghVishal VermaBhartendu Nath Mishra. (2015)
Characterization of
Plasmodium falciparum
Proteome at Asexual Blood Stages for Screening of Effective Vaccine Candidates: An Immunoinformatics Approach
. Immunology and Immunogenetics Insights 7, pages III.S24755.
Crossref
Crossref
Benedict R. Halbroth & Simon J. Draper. 2015.
1
49
.
Mauricio M. Rodrigues & Irene S. Soares. (2014) Gene-therapy for malaria prevention. Trends in Parasitology 30:11, pages 511-513.
Crossref
Crossref
Robert Schwenk, Margot DeBot, Michael Porter, Jennifer Nikki, Lisa Rein, Roberta Spaccapelo, Andrea Crisanti, Paul D. Wightman, Christian F. Ockenhouse & Sheetij Dutta. (2014) IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice. PLoS ONE 9:10, pages e111020.
Crossref
Crossref
Denise L. Doolan, Simon H. Apte & Carla Proietti. (2014) Genome-based vaccine design: the promise for malaria and other infectious diseases. International Journal for Parasitology 44:12, pages 901-913.
Crossref
Crossref
Katherine L. Doll & John T. Harty. (2014) Correlates of protective immunity following whole sporozoite vaccination against malaria. Immunologic Research 59:1-3, pages 166-176.
Crossref
Crossref
M. Spring, M. Polhemus & C. Ockenhouse. (2014) Controlled Human Malaria Infection. Journal of Infectious Diseases 209:suppl 2, pages S40-S45.
Crossref
Crossref
Ming Tan & Xi Jiang. (2014) Subviral particle as vaccine and vaccine platform. Current Opinion in Virology 6, pages 24-33.
Crossref
Crossref
Nora Céspedes, Eliécer Jiménez, Mary Lopez-Perez, Kelly Rubiano, Ingrid Felger, Pedro Alonso, Myriam Arévalo-Herrera, Giampietro Corradin & Sócrates Herrera. (2014) Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct. Vaccine 32:26, pages 3179-3186.
Crossref
Crossref
Sophie Schussek, Angela Trieu & Denise L. Doolan. (2014) Genome- and proteome-wide screening strategies for antigen discovery and immunogen design. Biotechnology Advances 32:2, pages 403-414.
Crossref
Crossref
Lais H. Teixeira, Cibele A. Tararam, Marcio O. Lasaro, Ariane G. A. Camacho, Jonatan Ersching, Monica T. Leal, Sócrates Herrera, Oscar Bruna-Romero, Irene S. Soares, Ruth S. Nussenzweig, Hildegund C. J. Ertl, Victor Nussenzweig & Mauricio M. Rodrigues. (2014) Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents. Infection and Immunity 82:2, pages 793-807.
Crossref
Crossref
Lander Foquet, Cornelus C. Hermsen, Geert-Jan van Gemert, Eva Van Braeckel, Karin E. Weening, Robert Sauerwein, Philip Meuleman & Geert Leroux-Roels. (2013) Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. Journal of Clinical Investigation 124:1, pages 140-144.
Crossref
Crossref
Franco M Buonaguro & Luigi BuonaguroSarah De BaetsKenny RooseBert SchepensXavier Saelens. 2014. Virus-like Particles in Vaccine Development. Virus-like Particles in Vaccine Development
68
84
.
Katja E. Boysen & Kai Matuschewski. (2013)
Inhibitor of Cysteine Proteases Is Critical for Motility and Infectivity of
Plasmodium
Sporozoites
. mBio 4:6.
Crossref
Crossref
Arnab K. Chatterjee. (2013) Cell-Based Medicinal Chemistry Optimization of High-Throughput Screening (HTS) Hits for Orally Active Antimalarials. Part 1: Challenges in Potency and Absorption, Distribution, Metabolism, Excretion/Pharmacokinetics (ADME/PK). Journal of Medicinal Chemistry 56:20, pages 7741-7749.
Crossref
Crossref
Robert Ménard, Joana Tavares, Ian Cockburn, Miles Markus, Fidel Zavala & Rogerio Amino. (2013) Looking under the skin: the first steps in malarial infection and immunity. Nature Reviews Microbiology 11:10, pages 701-712.
Crossref
Crossref
Monica Teixeira Andrade Leal, Ariane Guglielmi Ariza Camacho, Laís Helena Teixeira, Daniel Youssef Bargieri, Irene Silva Soares, Cibele Aparecida Tararam & Mauricio M. Rodrigues. (2013) Immunogenicity of Recombinant Proteins Consisting of Plasmodium vivax Circumsporozoite Protein Allelic Variant-Derived Epitopes Fused with Salmonella enterica Serovar Typhimurium Flagellin. Clinical and Vaccine Immunology 20:9, pages 1418-1425.
Crossref
Crossref
Mynthia Cabrera, Lecia L. Pewe, John T. Harty & Ute Frevert. (2013) In vivo CD8+ T Cell Dynamics in the Liver of Plasmodium yoelii Immunized and Infected Mice. PLoS ONE 8:8, pages e70842.
Crossref
Crossref
Julius Clemence R. Hafalla, Karolis Bauza, Johannes Friesen, Gloria Gonzalez-Aseguinolaza, Adrian V. S. Hill & Kai Matuschewski. (2013) Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling. PLoS Pathogens 9:5, pages e1003303.
Crossref
Crossref
Caroline Ogwang, Muhammed Afolabi, Domtila Kimani, Ya Jankey Jagne, Susanne H. Sheehy, Carly M. Bliss, Christopher J. A. Duncan, Katharine A. Collins, Miguel A. Garcia Knight, Eva Kimani, Nicholas A. Anagnostou, Eleanor Berrie, Sarah Moyle, Sarah C. Gilbert, Alexandra J. Spencer, Peninah Soipei, Jenny Mueller, Joseph Okebe, Stefano Colloca, Riccardo Cortese, Nicola K. Viebig, Rachel Roberts, Katherine Gantlett, Alison M. Lawrie, Alfredo Nicosia, Egeruan B. Imoukhuede, Philip Bejon, Britta C. Urban, Katie L. Flanagan, Katie J. Ewer, Roma Chilengi, Adrian V. S. Hill & Kalifa Bojang. (2013) Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults. PLoS ONE 8:3, pages e57726.
Crossref
Crossref
Kathrin Kastenmüller, Diego A. Espinosa, Lauren Trager, Cristina Stoyanov, Andres M. Salazar, Santosh Pokalwar, Sanjay Singh, Sheetij Dutta, Christian F. Ockenhouse, Fidel Zavala & Robert A. Seder. (2013)
Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4
+
T Cell Immunity and Protection in Mice
. Infection and Immunity 81:3, pages 789-800.
Crossref
Crossref
W. Ripley Ballou & Joe Cohen. 2013. Vaccines. Vaccines
1133
1137
.
Félix Calderón, David M. Wilson & Francisco-Javier Gamo. 2013.
97
151
.
Stella M Chenet, Lorena L Tapia, Ananias A Escalante, Salomon Durand, Carmen Lucas & David J Bacon. (2012) Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax. Malaria Journal 11:1.
Crossref
Crossref
Frederic Clement, Vincent Dewar, Eva Van Braeckel, Isabelle Desombere, Marianne Dewerchin, Christine Swysen, Marie-Ange Demoitié, Erik Jongert, Joe Cohen, Geert Leroux-Roels & Pierre Cambron. (2012) Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum. Malaria Journal 11:1.
Crossref
Crossref
Lauren Schwartz, Graham V Brown, Blaise Genton & Vasee S Moorthy. (2012) A review of malaria vaccine clinical projects based on the WHO rainbow table. Malaria Journal 11:1.
Crossref
Crossref
Fr?d?ric Coutant, Raul Yusef Sanchez David, Tristan F?lix, Aude Boulay, Laxmee Caleechurn, Philippe Souque, Catherine Thouvenot, Catherine Bourgouin, Anne-Sophie Beignon & Pierre Charneau. (2012) A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria. PLoS ONE 7:11, pages e48644.
Crossref
Crossref
Anna Caroline C Aguiar, Eliana MM da Rocha, Nicolli B de Souza, Tanos CC França & Antoniana U Krettli. (2012) New approaches in antimalarial drug discovery and development: a review. Memórias do Instituto Oswaldo Cruz 107:7, pages 831-845.
Crossref
Crossref
Susan M. Noh & Wendy C. Brown. 2012. Intracellular Pathogens II. Intracellular Pathogens II
330
365
.
Jeffrey A. Bailey, Tisungane Mvalo, Nagesh Aragam, Matthew Weiser, Seth Congdon, Debbie Kamwendo, Francis Martinson, Irving Hoffman, Steven R. Meshnick & Jonathan J. Juliano. (2012) Use of Massively Parallel Pyrosequencing to Evaluate the Diversity of and Selection on Plasmodium falciparum csp T-Cell Epitopes in Lilongwe, Malawi. The Journal of Infectious Diseases 206:4, pages 580-587.
Crossref
Crossref
Michael M. Kariuki, Ruguang Ou, Alexis N. LaCrue, Renee N. Roberts, Maggie S. Schlarman & Brenda T. Beerntsen. (2012) PFE0565w, a Plasmodium falciparum Protein Expressed in Salivary Gland Sporozoites. The American Journal of Tropical Medicine and Hygiene 86:6, pages 943-954.
Crossref
Crossref
Anjali Yadava, Saule Nurmukhambetova, Alexander V. Pichugin & Joanne M. Lumsden. (2012) Cross-Species Immunity Following Immunization With a Circumsporozoite Protein–Based Vaccine for Malaria. The Journal of Infectious Diseases 205:9, pages 1456-1463.
Crossref
Crossref
Vittoria Offeddu, Vandana Thathy, Kevin Marsh & Kai Matuschewski. (2012) Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. International Journal for Parasitology 42:6, pages 535-548.
Crossref
Crossref
D. S. Yamamoto, M. Sumitani, H. Nagumo, S. Yoshida & H. Matsuoka. (2012) Induction of antisporozoite antibodies by biting of transgenic Anopheles stephensi delivering malarial antigen via blood feeding. Insect Molecular Biology 21:2, pages 223-233.
Crossref
Crossref
Ennio De Gregorio & Rino Rappuoli. (2012) Vaccines for the future: learning from human immunology. Microbial Biotechnology 5:2, pages 149-155.
Crossref
Crossref
Satish Mishra, Ruth S. Nussenzweig & Victor Nussenzweig. (2012) Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity. Journal of Immunological Methods 377:1-2, pages 47-52.
Crossref
Crossref
Sócrates Herrera, Martha Lucia Quiñones, Juan Pablo Quintero, Vladimir Corredor, Douglas O. Fuller, Julio Cesar Mateus, Jose E. Calzada, Juan B. Gutierrez, Alejandro Llanos, Edison Soto, Clara Menendez, Yimin Wu, Pedro Alonso, Gabriel Carrasquilla, Mary Galinski, John C. Beier & Myriam Arévalo-Herrera. (2012) Prospects for malaria elimination in non-Amazonian regions of Latin America. Acta Tropica 121:3, pages 315-323.
Crossref
Crossref
Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth, Gathoni Kamuyu, Sumi Biswas, Anna L. Goodman, David H. Wyllie, Cécile Crosnier, Kazutoyo Miura, Gavin J. Wright, Carole A. Long, Faith H. Osier, Kevin Marsh, Alison V. Turner, Adrian V.S. Hill & Simon J. Draper. (2011) The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nature Communications 2:1.
Crossref
Crossref
Regitze L Thøgersen, Anthony A Holder, Adrian VS Hill, David E Arnot, Egeruan B Imoukhuede & Odile Leroy. (2011) Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?. Malaria Journal 10:1.
Crossref
Crossref
Matthew C Riley, Benjamin C Kirkup, Jake D Johnson, Emil P Lesho & Christian F Ockenhouse. (2011) Rapid whole genome optical mapping of Plasmodium falciparum. Malaria Journal 10:1.
Crossref
Crossref
Edmilson Rui, Carmen Fernandez-Becerra, Satoru Takeo, Sergi Sanz, Marcus VG Lacerda, Takafumi Tsuboi & Hernando A del Portillo. (2011) Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malaria Journal 10:1.
Crossref
Crossref
. (2011) Mixed results for a malaria vaccine. Nature Medicine 17:12, pages 1560-1561.
Crossref
Crossref
Joseph J. Campo, Carlota Dobaño, Jahit Sacarlal, Caterina Guinovart, Alfredo Mayor, Evelina Angov, Sheetij Dutta, Chetan Chitnis, Eusebio Macete, John J. Aponte & Pedro L. Alonso. (2011) Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens. PLoS ONE 6:10, pages e25779.
Crossref
Crossref
Satish Mishra, Urvashi Rai, Takayuki Shiratsuchi, Xiangming Li, Yannick Vanloubbeeck, Joe Cohen, Ruth S. Nussenzweig, Elizabeth A. Winzeler, Moriya Tsuji & Victor Nussenzweig. (2011) Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine 29:43, pages 7335-7342.
Crossref
Crossref
Joanne M. Lumsden, Sathit Pichyangkul, Utaiwan Srichairatanakul, Kosol Yongvanitchit, Amporn Limsalakpetch, Saule Nurmukhambetova, Jennifer Klein, Sylvie Bertholet, Thomas S. Vedvick, Steven G. Reed, Jetsumon Sattabongkot, Jason W. Bennett, Mark E. Polhemus, Christian F. Ockenhouse, Randall F. Howard & Anjali Yadava. (2011) Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion. Infection and Immunity 79:9, pages 3492-3500.
Crossref
Crossref
Joana M. Haussig, Kai Matuschewski & Taco W. A. Kooij. (2011) Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites. Molecular Microbiology 81:6, pages 1511-1525.
Crossref
Crossref
Angela Trieu, Matthew A. Kayala, Chad Burk, Douglas M. Molina, Daniel A. Freilich, Thomas L. Richie, Pierre Baldi, Philip L. Felgner & Denise L. Doolan. (2011) Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum Antigens. Molecular & Cellular Proteomics 10:9, pages M111.007948.
Crossref
Crossref
Steffen Borrmann & Kai Matuschewski. (2011) Targeting Plasmodium liver stages: better late than never. Trends in Molecular Medicine 17:9, pages 527-536.
Crossref
Crossref
Sze-Wah Tse, Andrea J Radtke & Fidel Zavala. (2011) Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development. Mem?rias do Instituto Oswaldo Cruz 106:suppl 1, pages 172-178.
Crossref
Crossref
Ariane Guglielmi Ariza Camacho, Laís Helena Teixeira, Daniel Youssef Bargieri, Silvia Beatriz Boscardin, Irene da Silva Soares, Ruth Sonntag Nussenzweig, Victor Nussenzweig & Mauricio Martins Rodrigues. (2011) TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium. Memórias do Instituto Oswaldo Cruz 106:suppl 1, pages 167-171.
Crossref
Crossref
Robin F. Anders. (2011) The case for a subunit vaccine against malaria. Trends in Parasitology 27:8, pages 330-334.
Crossref
Crossref
Steffen Borrmann & Kai Matuschewski. (2011) Protective immunity against malaria by ‘natural immunization’: a question of dose, parasite diversity, or both?. Current Opinion in Immunology 23:4, pages 500-508.
Crossref
Crossref
Joseph J. Campo, Timothy J. Whitman, Daniel Freilich, Timothy H. Burgess, Gregory J. Martin & Denise L. Doolan. (2011) Toward a Surrogate Marker of Malaria Exposure: Modeling Longitudinal Antibody Measurements under Outbreak Conditions. PLoS ONE 6:7, pages e21826.
Crossref
Crossref
Bruno Douradinha & Denise L. Doolan. (2011) Harnessing immune responses against Plasmodium for rational vaccine design. Trends in Parasitology 27:6, pages 274-283.
Crossref
Crossref
Julius Clemence Hafalla, Olivier Silvie & Kai Matuschewski. (2011) Cell biology and immunology of malaria. Immunological Reviews 240:1, pages 297-316.
Crossref
Crossref
Daniel Y. Bargieri, Irene S. Soares, Fabio T. M. Costa, Catarina J. Braga, Luis C. S. Ferreira & Mauricio M. Rodrigues. (2011) Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?. Journal of Parasitology Research 2011, pages 1-10.
Crossref
Crossref
Denise L. Doolan. (2011) Plasmodium immunomics. International Journal for Parasitology 41:1, pages 3-20.
Crossref
Crossref
David E. Arnot & Anja T.R. Jensen. 2011.
77
96
.
Carole A. Long & Fidel P. Zavala. 2010. The Immune Response to Infection. The Immune Response to Infection
587
597
.
Michael F. Good & Denise L. Doolan. (2010) Malaria Vaccine Design: Immunological Considerations. Immunity 33:4, pages 555-566.
Crossref
Crossref
Kathleen E. Rankin, Stefanie Graewe, Volker T. Heussler & Rebecca R. Stanway. (2010) Imaging liver-stage malaria parasites. Cellular Microbiology 12:5, pages 569-579.
Crossref
Crossref